Ocrelizumab/ocrevus. Initially as an infusion, but the doctor recommended monthly injections after neutropenic sepsis.

After moving to injections there was a hospitalisation for an upper respiratory tract infection, but not nearly as serious.

On a positive note, MRIs have shown no new lesions, and bio markers seem to show no relapses.